Dore GJ - Search Results

1

Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection.

Chang JJ, Sirivichayakul S, Avihingsanon A, Thompson AJ, Revill P, Iser D, Slavin J, Buranapraditkun S, Marks P, Matthews G, Cooper DA, Kent SJ, Cameron PU, Sasadeusz J, Desmond P, Locarnini S, Dore GJ, Ruxrungtham K, Lewin SR. Chang JJ, et al. Among authors: dore gj. J Virol. 2009 Aug;83(15):7649-58. doi: 10.1128/JVI.00183-09. Epub 2009 May 20. J Virol. 2009. PMID: 19458009 Free PMC article.

2

Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort.

Dore GJ, Hoy JF, Mallal SA, Li Y, Mijch AM, French MA, Cooper DA, Kaldor JM. Dore GJ, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Sep 1;16(1):39-43. doi: 10.1097/00042560-199709010-00006. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9377123

3

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.

Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ. Dore GJ, et al. AIDS. 1999 Jul 9;13(10):1249-53. doi: 10.1097/00002030-199907090-00015. AIDS. 1999. PMID: 10416530

4

Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee.

Dore GJ, Cooper DA, Barrett C, Goh LE, Thakrar B, Atkins M. Dore GJ, et al. J Infect Dis. 1999 Sep;180(3):607-13. doi: 10.1086/314942. J Infect Dis. 1999. PMID: 10438346 Clinical Trial.

5

Bridging the divide: global inequities in access to HIV/AIDS therapy.

Dore GJ, Cooper DA. Dore GJ, et al. Med J Aust. 2001 Dec 3-17;175(11-12):570-2. doi: 10.5694/j.1326-5377.2001.tb143729.x. Med J Aust. 2001. PMID: 11837843 No abstract available.

6

The impact of HIV therapy on co-infection with hepatitis B and hepatitis C viruses.

Dore GJ, Cooper DA. Dore GJ, et al. Curr Opin Infect Dis. 2001 Dec;14(6):749-55. doi: 10.1097/00001432-200112000-00014. Curr Opin Infect Dis. 2001. PMID: 11964895 Review.

7

HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy.

Lincoln D, Petoumenos K, Dore GJ; Australian HIV Observational Database. Lincoln D, et al. Among authors: dore gj. HIV Med. 2003 Jul;4(3):241-9. doi: 10.1046/j.1468-1293.2003.00152.x. HIV Med. 2003. PMID: 12859323 Free article.

8

Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001.

Law WP, Dore GJ, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA. Law WP, et al. Among authors: dore gj. AIDS. 2003 Oct 17;17(15):2191-9. doi: 10.1097/00002030-200310170-00007. AIDS. 2003. PMID: 14523276

9

Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus.

Dore GJ, Cooper DA, Pozniak AL, DeJesus E, Zhong L, Miller MD, Lu B, Cheng AK; 903 Study Team; 907 Study Team. Dore GJ, et al. J Infect Dis. 2004 Apr 1;189(7):1185-92. doi: 10.1086/380398. Epub 2004 Mar 12. J Infect Dis. 2004. PMID: 15031786 Clinical Trial.

10

HIV and hepatitis C coinfection within the CAESAR study.

Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ. Amin J, et al. Among authors: dore gj. HIV Med. 2004 May;5(3):174-9. doi: 10.1111/j.1468-1293.2004.00207.x. HIV Med. 2004. PMID: 15139984 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

528 results

Search Page

Filters